Cancer therapies can lead to a broad spectrum of cardiovascular complications. Among
these, cardiotoxicities remain of prime concern, but vascular toxicities have emerged as the …

The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs)
remains unclear, with scant literature available, mostly focusing on cardiovascular risk …

The potential usage of curcumin in diverse human diseases has been widely studied,
including arteriosclerosis (AS). This study focused on investigating the relationship between …

The four Janus kinases (JAKs) comprise a family of intracellular, nonreceptor tyrosine
kinases that first gained attention as signaling mediators of the type I and type II cytokine …

Myeloproliferative neoplasms (MPNs) are associated with a high risk of thrombotic and
hemorrhagic complications, especially in elderly patients. Atrial fibrillation (AF) and …

Polycythemia vera is a sporadic myeloproliferative disorder of increased red blood cell mass
affecting multiple organ systems. Associated thrombosis, hemorrhaging, and hyperviscosity …

BLOOD RESEARCH Page 1 This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) …

Polycythemia vera is a chronic myeloproliferative disorder marked by significant thrombotic
complications. Myocardial infarction and heart failure is the most common cause of death …

Myeloproliferative neoplasms (MPN s) with Janus kinase 2 (JAK 2) mutation are associated
with a high risk for occlusive vascular diseases. We report 2 cases of renovascular …

Objective: Unusual clinical course Background: Atherosclerosis and malignancies are
leading causes of morbidity and mortality worldwide. In lower-extremity arterial disease …